| Symbol | MBOT |
|---|---|
| Name | MICROBOT MEDICAL INC. |
| Sector | HEALTH CARE |
| Region | Middle East |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 175 DERBY ST.,BLD. 27, HINGHAM, Massachusetts, 02043, United States |
| Telephone | +1 781 - 875-3605 |
| Fax | — |
| — | |
| Website | https://www.microbotmedical.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000883975 |
| Description | Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The companys innovative platforms LIBERTY and Self-Cleaning Shunt SCS are in one of the fastest growing segments in healthcare. They continuously develop their technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen their product portfolio and create barriers of entry. Additional info from NASDAQ: |
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
Read more(99% Neutral) MICROBOT MEDICAL INC. (MBOT) Announces Business Combination
Read moreMicrobot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
Read moreMicrobot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
Read moreMicrobot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT06141694 | Assessment of Clin. Capabilities of LIBERTY® Endovascular Robotic System's Perf… | Na | Peripheral Vascular Interventions | Completed | 2024-07-02 | 2024-10-15 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| The LIBERTY® Robotic System | Other | Approved | Peripheral Vascular Interventions | COMPLETED | NCT06141694 |
| The LIBERTY® Robotic System | DEVICE | Approved | Peripheral Vascular Interventions | COMPLETED | NCT06141694 |